Masimo settles Shaklee, NIR pulse oximeter patent dispute
This article was originally published in Clinica
Executive Summary
Patient monitoring specialist Masimo (Irvine, California) has settled a pending patent dispute over pulse oximeter technology with its rivals Shaklee and NIR Diagnostics, ending legal proceedings after more than a year. All claims of patent litigation against Masimo were dismissed as the settlement was reached without Masimo incurring any liability to the plaintiffs. Shaklee had originally filed a lawsuit against Masimo in July 2007, claiming that that the latter’s patented pulse oximeters used calibration methods that had already been licensed. NIR joined the litigation alongside Shaklee, as both companies sought damages and an injunction preventing Masimo from selling its oximeters. Financial details of the settlement, if any, were not disclosed.